147 related articles for article (PubMed ID: 38649909)
1. Prevalence, clinical characteristics, and independent predictors of uveitic macular edema in an Asian population: a retrospective cohort study.
Tungsattayathitthan U; Jenjanya S; Choopong P; Sanphan W; Tesavibul N; Boonsopon S
BMC Ophthalmol; 2024 Apr; 24(1):181. PubMed ID: 38649909
[TBL] [Abstract][Full Text] [Related]
2. Frequency and Treatment Regimens of Macular Edema in 1946 Consecutive Patients with Noninfectious Uveitis at a Tertiary Ophthalmic Center in Shaanxi, China.
Xue YQ; Xiao JA; Chen Y
Ophthalmol Ther; 2023 Oct; 12(5):2609-2619. PubMed ID: 37440091
[TBL] [Abstract][Full Text] [Related]
3. Disease of the Year: Differential Diagnosis of Uveitic Macular Edema.
Agarwal A; Pichi F; Invernizzi A; Gupta V
Ocul Immunol Inflamm; 2019; 27(1):72-88. PubMed ID: 30273513
[TBL] [Abstract][Full Text] [Related]
4. En face optical coherence tomography patterns in patients with angiographically documented uveitic macular edema: a cross-sectional retrospective study.
Karti O; Kaya M; Ataş F; Saatci AO
Int Ophthalmol; 2021 Oct; 41(10):3303-3312. PubMed ID: 34014462
[TBL] [Abstract][Full Text] [Related]
5. Patterns of Macular Edema in Uveitis as Diagnosed by Optical Coherence Tomography in Tertiary Eye Center.
Gupta S; Shah DN; Joshi SN; Aryal M; Puri LR
Nepal J Ophthalmol; 2018 Jan; 10(19):39-46. PubMed ID: 31056575
[TBL] [Abstract][Full Text] [Related]
6. Topical interferon therapy in uveitic macular edema.
Kawali A; Sanjay S; Mohan A; Mahendradas P; Shetty R
Indian J Ophthalmol; 2022 Dec; 70(12):4357-4361. PubMed ID: 36453344
[TBL] [Abstract][Full Text] [Related]
7. Predictors for functional and anatomic outcomes in macular edema secondary to non-infectious uveitis.
Matas J; Llorenç V; Fonollosa A; Esquinas C; Diaz-Valle D; Berasategui B; Mesquida M; Artaraz J; Rios J; Adan A
PLoS One; 2019; 14(1):e0210799. PubMed ID: 30677041
[TBL] [Abstract][Full Text] [Related]
8. The impact of macular edema on visual function in intermediate, posterior, and panuveitis.
Taylor SR; Lightman SL; Sugar EA; Jaffe GJ; Freeman WR; Altaweel MM; Kozak I; Holbrook JT; Jabs DA; Kempen JH
Ocul Immunol Inflamm; 2012 Jun; 20(3):171-81. PubMed ID: 22530874
[TBL] [Abstract][Full Text] [Related]
9. Medical Therapy of Uveitic Macular Edema: Biologic Agents.
Radosavljevic A; Agarwal M; Bodaghi B; Smith JR; Zierhut M
Ocul Immunol Inflamm; 2020 Nov; 28(8):1239-1250. PubMed ID: 32058830
[No Abstract] [Full Text] [Related]
10. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema.
Kempen JH; Sugar EA; Jaffe GJ; Acharya NR; Dunn JP; Elner SG; Lightman SL; Thorne JE; Vitale AT; Altaweel MM;
Ophthalmology; 2013 Sep; 120(9):1852-9. PubMed ID: 23706700
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Macular Edema in Uveitis.
Accorinti M; Okada AA; Smith JR; Gilardi M
Ocul Immunol Inflamm; 2019; 27(2):169-180. PubMed ID: 30821631
[TBL] [Abstract][Full Text] [Related]
12. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
[TBL] [Abstract][Full Text] [Related]
13. Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.
Grajewski RS; Boelke AC; Adler W; Meyer S; Caramoy A; Kirchhof B; Cursiefen C; Heindl LM
Eye (Lond); 2016 Nov; 30(11):1415-1423. PubMed ID: 27391933
[TBL] [Abstract][Full Text] [Related]
14. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema.
Levin MH; Pistilli M; Daniel E; Gangaputra SS; Nussenblatt RB; Rosenbaum JT; Suhler EB; Thorne JE; Foster CS; Jabs DA; Levy-Clarke GA; Kempen JH;
Ophthalmology; 2014 Feb; 121(2):588-95.e1. PubMed ID: 24332536
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in uveitis].
Albaroudi N; Tijani M; Boutimzine N; Cherkaoui O; Laghmari M
J Fr Ophtalmol; 2017 Nov; 40(9):751-757. PubMed ID: 28882393
[TBL] [Abstract][Full Text] [Related]
16. Relationship of Epiretinal Membrane Formation and Macular Edema Development in a Large Cohort of Uveitic Eyes.
Mustafi D; Do BK; Rodger DC; Rao NA
Ocul Immunol Inflamm; 2021 Jul; 29(5):915-921. PubMed ID: 31961201
[No Abstract] [Full Text] [Related]
17. Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.
Saade JS; Istambouli R; AbdulAal M; Antonios R; Hamam RN
Middle East Afr J Ophthalmol; 2021; 28(2):98-103. PubMed ID: 34759667
[TBL] [Abstract][Full Text] [Related]
18. The effects of intravitreal bevacizumab in infectious and noninfectious uveitic macular edema.
Al-Dhibi H; Hamade IH; Al-Halafi A; Barry M; Chacra CB; Gupta V; Tabbara KF
J Ophthalmol; 2014; 2014():729465. PubMed ID: 25136452
[TBL] [Abstract][Full Text] [Related]
19. Behavior of hyperreflective foci in non-infectious uveitic macular edema, a 12-month follow-up prospective study.
Berasategui B; Fonollosa A; Artaraz J; Ruiz-Arruza I; Ríos J; Matas J; Llorenç V; Diaz-Valle D; Sastre-Ibañez M; Arriola-Villalobos P; Adan A
BMC Ophthalmol; 2018 Jul; 18(1):179. PubMed ID: 30029623
[TBL] [Abstract][Full Text] [Related]
20. Intensive topical interferon therapy in uveitic macular edema.
Kawali A; Sanjay S; Mohan A; Mahendradas P; Shroff S; Shetty R
Indian J Ophthalmol; 2022 Aug; 70(8):2986-2989. PubMed ID: 35918958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
